Publications
Publications
Show Results For
- All HBS Web
(2,840)
- Faculty Publications (467)
- March 2018 (Revised July 2018)
- Case
Cadre
By: Thomas R. Eisenmann, Scott Duke Kominers and David Lane
Late in 2017, CEO Ryan Williams and his team debated whether Cadre should become not only a technology-enabled investment manager, but also an online trading exchange providing high levels of liquidity for investors in commercial real estate (CRE) equity. Cadre was a... View Details
- March 2018
- Teaching Note
Twine Health
By: Robert S. Huckman and Ariel D. Stern
In late 2014, Dr. John Moore (CEO), Frank Moss (chairman), and Scott Gilroy (CTO) of Twine Health (Twine) had to resolve several challenges that threatened to restrict the widespread dissemination of its sole product, Twine. Twine was a cloud-based platform that... View Details
- March 2018
- Case
Sachem Head's Activism at Autodesk
By: Suraj Srinivasan and Quinn Pitcher
In 2015, activist hedge fund Sachem Head Capital, led by founder Scott Ferguson, launched an activist campaign at computer aided design (CAD) software maker Autodesk. The activist campaign, waged mainly in private, was over Autodesk's lackluster financial performance,... View Details
- January 2018 (Revised January 2019)
- Case
ZappRx
By: Jeffrey J. Bussgang and Olivia Hull
In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest... View Details
- January 2018
- Article
Innovation Incentives and Biomarkers
By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra
Previously, we have discussed the importance of economic incentives in shaping markets for precision medicines. Here we consider incentives for biomarker development, including discovery and establishment. Biomarkers can reveal valuable information regarding diagnosis... View Details
- November 2017 (Revised July 2018)
- Case
Royal Philips: Designing Toward Profound Change
By: Srikant M. Datar, Rajiv Lal and Caitlin N. Bowler
This case explores Royal Philips CEO Frans van Houten's bold use of design research to inform a critical strategic decision: Should Philips leave its storied lighting business behind in favor of complete focus on health technology and consumer lifestyle products?... View Details
- Article
The IT Transformation Health Care Needs
By: Nikhil R. Sahni, Robert S. Huckman, Anuraag Chigurupati and David M. Cutler
In recent years, health care organizations have made sizable investments in information technology. They’ve used their IT systems to replace paper records with electronic ones and to improve billing processes, thereby boosting revenue. But so far, IT has been of little... View Details
- October 2017 (Revised April 2024)
- Case
Snap Inc. Goes Public (A)
By: Lynn Sharp Paine and Will Hurwitz
Snap Inc.’s chairman must decide how to address investor concerns about the company’s unprecedented plans to issue only non-voting shares in its upcoming IPO. The case is set in early 2017 following the public availability of Snap’s IPO filing with the U.S. Securities... View Details
Keywords: Ethics; Capital Structure; Corporate Accountability; Governing and Advisory Boards; Corporate Governance; Going Public; Business and Shareholder Relations; Leadership; Management; Mobile and Wireless Technology; Venture Capital; Information Technology Industry; Information Technology Industry; Information Technology Industry; United States; California
- July 31, 2017
- Article
A Commitment Contract to Achieve Virologic Suppression in Poorly Adherent Patients with HIV/AIDS
By: Marcella Alsan, John Beshears, Wendy S. Armstrong, James J. Choi, Brigitte C. Madrian, Minh Ly T. Nguyen, Carlos Del Rio, David Laibson and Vincent C. Marconi
Objective: Assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence.
Design: Single-center pilot randomized clinical trial and a... View Details
- July 2017 (Revised October 2017)
- Supplement
Becton Dickinson: Innovation and Growth (B)
By: Raffaella Sadun, Michael Beer and James Weber
This (B) case supplements the (A) case by providing additional information and updates through early 2016. View Details
- May 2017
- Supplement
Betfair (B), (C), and (D) Case Slides
By: Ramon Casadesus-Masanell and John Heilbron
Contains slides related to the Betfair B, C, and D cases.
Abstracts:
B) Buoyed by success in the market for gambling contracts, Betfair attempts to enter the market for financial products using its exchange model.
C) Prompted by a takeover bid from... View Details
Abstracts:
B) Buoyed by success in the market for gambling contracts, Betfair attempts to enter the market for financial products using its exchange model.
C) Prompted by a takeover bid from... View Details
- May 2017
- Supplement
Betfair (B)
By: Ramon Casadesus-Masanell, John Heilbron and Neil Campbell
Buoyed by success in the market for gambling contracts, Betfair attempts to enter the market for financial products using its exchange model. View Details
- 2017
- Working Paper
Digital Labor Markets and Global Talent Flows
By: John Horton, William R. Kerr and Christopher Stanton
Digital labor markets are rapidly expanding and connecting companies and contractors on a global basis. We review the environment in which these markets take root, the micro- and macro-level studies of their operations, their ongoing evolution and recent trends, and... View Details
- May 2017
- Article
Psychologically Informed Implementations of Sugary-Drink Portion Limits
By: Leslie John, Grant Donnelly and Christina Roberto
In 2012, the New York City Board of Health prohibited restaurants from selling sugary drinks in containers larger than 16 ounces. Although a state court ruled that the Board of Health did not have the authority to implement such a policy, it remains a legally viable... View Details
- March 2017 (Revised March 2017)
- Case
OpenNotes
By: Jeffrey Rayport and Annelena Lobb
In 2017, executives at OpenNotes, a national movement to improve the relationship between doctors and patients by sharing doctors’ visit notes about patients with patients, were considering options in efforts to achieve scale. The movement hoped to reach 50 million... View Details
- February 2017 (Revised June 2017)
- Case
ExxonMobil: Business as Usual? (A)
By: George Serafeim, Shiva Rajgopal and David Freiberg
Climate change was becoming an important societal and business issue as more governments were introducing climate change related regulations and investors became increasibly worried about stranded assets within oil and gas firms. In September 2016, the U.S. Securities... View Details
- January 2017 (Revised May 2020)
- Case
Sesame Workshop (A): Bringing Big Bird Back to Health
By: Rosabeth Moss Kanter, Ryan Raffaelli and Jonathan Cohen
Sesame Workshop was transforming in 2016. CEO Jeff Dunn had reorganized and shifted the iconic institution to respond to digital disruption and a consensus culture. This case examines his efforts to turn Sesame Workshop around. It notes Sesame's storied history and the... View Details
- January 2017 (Revised March 2021)
- Case
Fitbit
By: Regina E. Herzlinger, Christine Snively and Sarah Mehta
In 2019, Fitbit lost its leadership in the wearable sensor market to Apple and to cheaper alternatives.
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details
- Article
One Obstacle to Curing Cancer: Patient Data Isn't Shared
By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States